Glycoproteins and glycoproteomics in pancreatic cancer

doi:10.3748/wjg.v22.i42.9288

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12030)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

962

WORD

270

HTML

8236

Figures (1-2)

172

Sum=9640

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1001

Download

1389

Sum=2390

Nov 14, 2016 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (51)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Nov 14, 2016; 22(42): 9288-9299
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9288

Glycoproteins and glycoproteomics in pancreatic cancer

Sheng Pan, Teresa A Brentnall, Ru Chen

Sheng Pan, Teresa A Brentnall, Ru Chen, Department of Medicine, University of Washington, Seattle, WA 98195, United States

Author contributions: Pan S wrote the manuscript; Chen R and Brentnall TA reviewed and contributed to the manuscript.

Conflict-of-interest statement: The authors declare no conflict of interests for this article.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Correspondence to: Sheng Pan, PhD, Department of Medicine, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, United States. shengp@medicine.washington.edu

Telephone: +1-206-6853632 Fax: +1-206-6859478

Received: June 29, 2016
Peer-review started: June 30, 2016
First decision: August 8, 2016
Revised: August 23, 2016
Accepted: September 14, 2016
Article in press: September 14, 2016
Published online: November 14, 2016

Core Tip

Core tip: Protein glycosylation plays an important role in pancreatic tumorigenesis. Malignance induced changes in protein glycosylation can profoundly impact the function of a protein in multiple ways. One approach for developing better diagnostic and therapeutic strategies in pancreatic cancer involves targeting cancer-associated aberrant glycosylation. This review discusses the recent discoveries in glycoproteomics study of pancreatic cancer.